Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma

specific

An intrahepatic cholangiocarcinoma that has spread extensively to other anatomic sites or is no longer responding to treatment.

Centers

Active Trials

—

Cancer Funding

Top Centers for Cohort 4a and 4b: Intrahepatic Cholangiocarcinoma(11)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Active Trials	Cancer Funding	Score
1	Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive	—	—	54.5
2	The University of Texas MD Anderson Cancer CenterHouston, TX NCI Comprehensive	—	—	54.5
3	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive	—	—	54.5
4	University of Colorado Cancer CenterAurora, CO NCI Comprehensive	—	—	54.5
5	Sylvester Comprehensive Cancer CenterMiami, FL NCI Clinical	—	—	54.5
6	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive	—	—	54.5
7	Medical College of Wisconsin Cancer CenterMilwaukee, WI	—	—	54.5
8	Holden Comprehensive Cancer CenterIowa City, IA NCI Comprehensive	—	—	54.5
9	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive	—	—	54.5
10	University of Illinois Cancer CenterChicago, IL	—	—	54.5
11	Boston University Cancer CenterBoston, MA	—	—	54.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →